Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 5 peer-reviewed journal articles Updated
Hepatobiliary Surgery

Building Your Care Team & First Visit Prep

At a Glance

For perihilar cholangiocarcinoma, building a multidisciplinary care team at a high-volume hepatobiliary center is crucial. Bring your raw imaging discs, original pathology slides, and recent lab results to your first visit to ensure an accurate review by specialized surgeons and oncologists.

Because perihilar cholangiocarcinoma (pCCA) is a rare and technically complex disease, the quality of your care team is critical. You are not just looking for a doctor; you are looking for a highly specialized “system” equipped to handle this exact disease [1].

The Non-Negotiable: High-Volume Centers

For pCCA, radical surgery is technically demanding, involving intricate vascular and biliary reconstruction [2]. If your current hospital only sees a few cases of bile duct cancer a year, seeking a second opinion at a high-volume hepatobiliary center is a critical step in self-advocacy.

Your Multidisciplinary Team (MDT)

A “gold-standard” care team is a Multidisciplinary Tumor Board (MDT)—a group of specialists who meet to discuss your specific scans and pathology [1][3]. Your team should ideally include:

  • Hepatobiliary (HPB) Surgeon: A surgeon who specializes exclusively in the liver and bile ducts.
  • Transplant Surgeon: Essential for evaluating if you qualify for the Mayo Clinic transplant protocol.
  • Interventional Radiologist: The specialist who places stents or drains to keep bile flowing and manage jaundice [4].
  • Medical Oncologist: A specialist who coordinates chemotherapy and immunotherapy.
  • Specialized Radiologist & Pathologist: Experts trained to avoid misdiagnosing pCCA for mimics like IgG4-SC [5].

First Visit Checklist: What to Bring

High-volume centers will want to verify everything themselves. To avoid delays, ensure you bring:

  • Imaging on Disc: CDs or digital links containing your CT and MRI/MRCP scans in raw “DICOM” format, along with the typed radiology reports.
  • Pathology Slides: If you had a biopsy, request the actual “glass slides” and “blocks” from the original hospital, along with the typed pathology report.
  • Recent Lab Results: Specifically your CA 19-9, bilirubin levels, and liver function tests.

Managing “Scanxiety” and Wait Times

The diagnostic process for pCCA can feel agonizingly slow. Wait times for genetic profiling (NGS) can take weeks, and waiting for tumor boards to meet can cause severe anxiety (often called “scanxiety”).

  • Request a Timeline: Ask exactly when results will be released or when the tumor board will meet.
  • Use Your Navigator: Most high-volume centers have nurse navigators or social workers. Reach out to them; they are specifically trained to help you navigate the logistical and emotional stress of this waiting period.

Common questions in this guide

Why do I need to be treated at a high-volume center for perihilar cholangiocarcinoma?
Perihilar cholangiocarcinoma is a rare and complex disease requiring highly specialized surgical techniques like vascular and biliary reconstruction. High-volume hepatobiliary centers have the experienced multidisciplinary teams necessary to safely manage this specific type of bile duct cancer.
Which doctors should be on my pCCA care team?
Your core team should include a hepatobiliary (HPB) surgeon, an interventional radiologist, a medical oncologist, and specialized radiologists and pathologists. It is also beneficial to consult a transplant surgeon to see if you qualify for specific transplant protocols.
What should I bring to my first appointment?
You should bring your raw imaging on a DICOM disc along with typed reports, original glass pathology slides and blocks from any biopsies, and recent lab results. Key lab results to have on hand include your CA 19-9 tumor marker, bilirubin levels, and liver function tests.
Can I consult a transplant surgeon if my tumor is considered unresectable?
Yes, you should ask to meet with a transplant surgeon. Even if your tumor is currently considered unresectable, you may still qualify for highly specialized liver transplant protocols available at certain centers.
How can I deal with the anxiety of waiting for my test results?
Ask your care team for a specific timeline of when genetic profiling or tumor board results will be ready so you know what to expect. You can also reach out to a nurse navigator or hospital social worker, who are specifically trained to help you manage the emotional stress of waiting.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.How many perihilar cholangiocarcinoma surgeries do you personally perform each year?
  2. 2.Will my case be reviewed by a formal multidisciplinary tumor board?
  3. 3.Can I meet with a transplant surgeon to discuss all my options, even if the tumor is currently considered unresectable?
  4. 4.Who will be my main point of contact (like a nurse navigator) to help coordinate appointments?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (5)
  1. 1

    Multi-Disciplinary Care of Hilar Cholangiocarcinoma: Review of Guidelines and Recent Advancements.

    Padmanaban V, Ruff SM, Pawlik TM

    Cancers 2023; (16(1)) doi:10.3390/cancers16010030.

    PMID: 38201457
  2. 2

    Effects of portal vein resection and hepatic artery resection on long-term survival in Klatskin tumor: a meta-analysis.

    Song Y, Zhang Y, Zhen Z, Huang Z

    World journal of surgical oncology 2022; (20(1)):230 doi:10.1186/s12957-022-02692-1.

    PMID: 35821140
  3. 3

    Liver transplantation as an alternative for the treatment of perihilar cholangiocarcinoma: A critical review.

    Andraus W, Tustumi F, Santana AC, et al.

    Hepatobiliary & pancreatic diseases international : HBPD INT 2024; (23(2)):139-145 doi:10.1016/j.hbpd.2024.01.003.

    PMID: 38310060
  4. 4

    Imaging Diagnosis of Intrahepatic and Perihilar Cholangiocarcinoma: Recent Advances and Challenges.

    Joo I, Lee JM, Yoon JH

    Radiology 2018; (288(1)):7-13 doi:10.1148/radiol.2018171187.

    PMID: 29869969
  5. 5

    Klatskin tumors and "Klatskin-mimicking lesions": our 22-year experience.

    Tsalis K, Parpoudi S, Kyziridis D, et al.

    Revista espanola de enfermedades digestivas 2019; (111(2)):121-128 doi:10.17235/reed.2018.5749/2018.

    PMID: 30421957

This page provides educational information on preparing for a perihilar cholangiocarcinoma appointment. It is not a substitute for professional medical advice or a formal consultation with a hepatobiliary specialist.

Get notified when new evidence is published on Perihilar cholangiocarcinoma.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.